Stock Ratings / Technology / VREX / insiders

NANO (58) CRCT (80) ERII (72) AZTA (51) ⌘ Pro Terminal →

Varex Imaging Corporation (VREX) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$18.44 -0.05% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $18.40

Varex Imaging Corporation (VREX) carries a Roarable Rating of D+ (Sell) with 52/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 52/100 (D+) historically posted market-perform odds over rolling 90-day windows (-1.1% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $776.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on VREX Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is VREX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-01, Varex Imaging Corporation (NASDAQ: VREX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 52/100 at a spot price of $18.44 (-0.05% 1D, market cap $776.3M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 8/20. Across 714 tracked Technology issuers, VREX ranks #377 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does VREX compare to NANO and CRCT in the Technology sector?

▼

Within the Technology sector (Industrial Machinery/Components), VREX carries a Roarable D+ (52/100 RQD), trailing P/E of N/A, gross margin of 34.4%, and ROIC of -3.0%. By comparison, NANO (Forge Nano Holdings Inc.) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $535.2M) and CRCT (Cricut Inc. (Class A)) posts a B+ grade (80/100 RQD, P/E 16.9x, ROIC 85.0%, cap $1.29B). Among the 5-stock peer group, ERII leads on earnings multiple (15.8x) while CRCT leads on capital efficiency (85.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for VREX?

▼

Per VREX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-10-03, CIK 0001681622), Varex Imaging Corporation generated $844.6M in revenue (+4.1% YoY), -$70.3M in net income, and $18.8M in free cash flow against $1.10B in total assets and $366.2M in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $18.40 (-0.20%)🧬 Disciplined Float (-0.12% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 2.2% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 52/100 (D+) historically posted market-perform odds over rolling 90-day windows (-1.1% avg 90D alpha vs SPY • 50.1% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE-2.7% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for VREX)Realized 20D OHLCV Swing Band: ±1.8%

Deterministic 5-Pillar Attribution (52/100 Composite)

🔍 WHY VREX SCORES 52/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+13/20 pts (25% of score)

FRED Regime × Technicals: 98% of 52W Range • RSI-14 at 59.7 (BULLISH MOMENTUM)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+12/20 pts (23% of score)

Altman Z-Score 1.96 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution8/20 pts (-12 pt drag)

Disciplined Float (-0.12% YoY Shares) & executive Form 4 sales trim 12 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$18.46-0.3% Next Q

Q2 (-2Q)

Grade C$18.41+0.1% Next Q

Q3 (-1Q)

Grade C$18.42+0.1% Next Q

Current

Grade D+$18.44-1.1% Hist 90D α

Trajectory: C (60) → D+ (52)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a VREX Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While VREX currently carries a cautious 52/100 (D+) rating due to Insider Conviction & Share Dilution (8/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($18.46) and Max Pain ($19.36) forces dealer call-delta covering toward $21.17.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.12% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $VREX• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “VREX Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 52%NO 48%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

VREX Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (VREX)

No recent open-market Form 4 cluster sales or emergency dumps flagged on VREX. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring VREX)

✓Walkthrough of VREX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

VREX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +58.28%⚡ TESTING RESISTANCE

2026-10-30O $18.44H $18.47L $18.42C $18.44VOL 460.7K

RES: $18.50SUP: $18.32SMA50: $18.46SMA200: $13.60

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

VREX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 VREX Butterfly Map → + Track VREX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +4.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on VREX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for VREX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for VREX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (VREX)

Technology Rank #377 of 714 ⚔️ NANO vs VREX Full Matrix →

1. Head-to-Head Technology Peer Comparison (VREX vs. NANO, CRCT, ERII, AZTA)

Industry: Industrial Machinery/Components (208 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Varex Imaging Corporation (VREX) ranks #377 by composite RQD confidence (52/100, grade D+) and #377 by equity capitalization ($776.3M). Within this direct 5-issuer industry benchmark cohort, ERII leads on earnings valuation at 15.8x trailing P/E, while CRCT leads on capital efficiency and profitability with 85.0% ROIC and 55.1% gross margin. CRCT currently holds the highest overall quantitative score in the immediate peer group at 80/100 (B+) compared with VREX at 52/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
VREX ACTIVE Varex Imaging Corporation	D+	52/100	—	34.4%	-3.0%	-0.05%	$776.3M	Benchmark Subject
NANO Forge Nano Holdings Inc.	D+	58/100	—	—	—	-1.42%	$535.2M	/nano-vs-vrex →
CRCT Cricut Inc. (Class A)	B+	80/100	16.9x	55.1%	85.0%	+1.81%	$1.29B	/crct-vs-vrex →
ERII Energy Recovery Inc.	B	72/100	15.8x	65.1%	11.9%	+2.45%	$363.4M	/erii-vs-vrex →
AZTA Azenta Inc.	D	51/100	—	45.5%	-1.5%	+1.58%	$1.81B	/azta-vs-vrex →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-10-03 • CIK 0001681622

In its most recent audited fiscal period (FY2025, filed 2025-10-03), Varex Imaging Corporation (VREX) reported GAAP revenue of $844.6M (+4.1% vs. FY2024 revenue of $811.0M , and -5.5% cumulative change since FY2023) , GAAP net income of -$70.3M, operating cash flow of $41.7M, and free cash flow of $18.8M (-7.8% YoY). On the balance sheet, VREX closed FY2025 with $1.10B in total assets against $366.2M in total debt (Altman Z-Score: 1.96, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-10-03	$844.6M	-$70.3M	$41.7M	$18.8M	$1.10B	$366.2M
FY2024 (FY)	2024-09-27	$811.0M	-$48.8M	$47.3M	$20.4M	$1.33B	$565.6M
FY2023 (FY)	2023-09-29	$893.4M	$47.4M	$108.4M	$108.4M	—	—

3. VREX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is VREX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does VREX compare to NANO and CRCT in the Technology sector?

What are the biggest fundamental strengths and SEC risk factors for VREX?

Where is VREX trading relative to its 50-day, 200-day, and 52-week technical levels?

VREX last traded at $18.44 (-0.05% on volume of 1,043,534 shares), positioning the stock -0.11% below its 50-day simple moving average ($18.46) and +35.59% above its 200-day simple moving average ($13.60). Across its 52-week range of $9.09 to $18.63, VREX sits at the 98.0% percentile with a 14-day RSI of 59.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±1.8% ($18.11 to $18.77).

VREX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are VREX insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies VREX leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: VREX RQD Cockpit VREX 12M Forecast VREX Earnings & Move VREX Dividends & DRIP VREX Insiders & 13F VREX Whale Options VREX Profit Sankey VREX News & Why